Army Study Leads to Approval of New Smallpox Vaccine
October 16, 2019
October 16, 2019
SAN ANTONIO, Texas, Oct. 16 -- The U.S. Army Medicine issued the following news:
Thanks in part to Army scientists, the world has gained a new weapon in the fight against one of history's most feared diseases: smallpox.
A new vaccine approved on Sept. 24 by the U.S. Food and Drug Administration (FDA), prevents both smallpox and the related disease monkeypox in adults. Marketed under the brand name JYNNEOS, the vaccine was developed by biotechnology firm Bavarian Nordic . . .
Thanks in part to Army scientists, the world has gained a new weapon in the fight against one of history's most feared diseases: smallpox.
A new vaccine approved on Sept. 24 by the U.S. Food and Drug Administration (FDA), prevents both smallpox and the related disease monkeypox in adults. Marketed under the brand name JYNNEOS, the vaccine was developed by biotechnology firm Bavarian Nordic . . .